TABLE 3 from A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial
收藏aacr.figshare.com2024-01-04 更新2025-03-26 收录
下载链接：
https://aacr.figshare.com/articles/dataset/TABLE_3_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942905/1
下载链接
链接失效反馈官方服务：
资源简介：
AEs with frequency ≥10% in either trial arm (safety population)
在任一试验臂（安全性人群）中频率≥10%的AEs（不良事件）
提供机构：
American Association for Cancer Research
